IDH1 mutations are associated with the CpG island hypermethylation phenotype (MvdB and PF, submitted), and promoter hypermethylation in cancer often occurs in the promoter regions of tumor suppressor genes [35], [36]. The gene discussed is IDH1; the disease is neoplasm.